
Quarterly ResultJul 29, 2026, 04:34 PM
Tenet Healthcare Q2 EPS $9.84, Revenue $5.63B; Conifer Deal $1.9B
AI Summary
Tenet Healthcare reported strong financial results for the second quarter and first six months of 2026, with diluted EPS significantly increasing to $9.84 for Q2 and net operating revenues rising to $5.63 billion. The company also highlighted the strategic Omnibus Agreement with CHI, which includes a $1.9 billion payment and the redemption of CHI's minority interest in Conifer. Year-to-date net income available to common shareholders more than doubled to $1.53 billion, reflecting robust performance and the impact of the contract termination revenue.
Key Highlights
- Conifer Omnibus Agreement includes $1.9B payment from CHI and $540M minority interest redemption.
- Q2 diluted EPS was $9.84, significantly up from $3.14 in Q2 2025.
- Q2 net operating revenues reached $5.63 billion, an increase from $5.27 billion in Q2 2025.
- Six-month net income available to common shareholders was $1.53 billion, up from $694 million YoY.
- Six-month revenue from contract termination totaled $826 million.
- Repurchased $1.36 billion of common stock during the six months ended June 30, 2026.
- Cash and cash equivalents stood at $2.17 billion as of June 30, 2026.
- Goodwill increased by $239 million to $11.44 billion, primarily in Ambulatory Care.
Price Impact
More from THC